Free National NPI Number Registry

Dr. Peter Logalbo

Home >Dr. Peter Logalbo

 

NPI Number Detailed Information

Provider Information:

Name: Dr. Peter Logalbo
Gender: M
Provider License Number If Given: MA054270

NPI Information:

NPI: 1700825395
Entity Type
(Individual or Organization):
1-ind
Enumeration Date: 6/6/2006

Last Update Date: 4/3/2019

Reputation Report:

Provider Business Mailing Address:

Address: 660 WHITE PLAINS RD FL 4
Tarrytown, NY 10591
Phone Number: 9149842546
Fax Number:

Provider Business Practice Location Address:

Address: 1 CROSFIELD AVENUE SUITE 201
West Nyack, NY 10994
Phone Number: 8457271370
Fax Number: 8457271377

Provider Taxonomy:

Primary: 207KA0200X
Secondary (if any): 207KA0200X
State: NY

Top Doctors in NY

 

About Dr. Peter Logalbo

Dr. Peter Logalbo (DR. PETER LOGALBO ) is Definition Allergy & Immunology Physician in West Nyack, NY. The NPI Number for Dr. Peter Logalbo is 1700825395.
The current location address for Dr. Peter Logalbo is 1 CROSFIELD AVENUE SUITE 201 West Nyack, NY 10994 and the contact number is 9149842546 and fax number is . The mailing address for Dr. Peter Logalbo is 660 WHITE PLAINS RD FL 4 Tarrytown, NY 10591- 8457271370 (mailing address contact number - 9149842546).
Definition to come...

Provider Business Location on Map

FAQs:

What is the NPI Number for Dr. Peter Logalbo ?


Answer: The NPI Number for Dr. Peter Logalbo is 1700825395

Where is Dr. Peter Logalbo located?


Answer: Dr. Peter Logalbo is located at 1 CROSFIELD AVENUE SUITE 201 West Nyack, NY 10994.

What is the specialty for Dr. Peter Logalbo ?


Answer: The Specialty of Dr. Peter Logalbo is Definition Allergy & Immunology Physician.

Are there any online reviews for Dr. Peter Logalbo ?


Answer: Yes! Check It Now.

Are there any other health care providers in West Nyack, NY?


Answer: Yes, there are given below...

Medicare Physician & Other Practitioners

Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Dr. Peter Logalbo

Number of HCPCS 17
Number of Medicare Beneficiaries 816
Number of Services 34617
Total Submitted Charge Amount 957739.16
Total Medicare Allowed Amount 450091.05
Total Medicare Payment Amount 344853.7
Total Medicare Standardized Payment Amount 265485.49
Drug Suppress Indicator
Number of HCPCS Associated With Drug Services 0
Number of Medicare Beneficiaries With Drug Services 0
Number of Drug Services 0
Total Drug Submitted Charge Amount 0
Total Drug Medicare Allowed Amount 0
Total Drug Medicare Payment Amount 0
Total Drug Medicare Standardized Payment Amount 0
Medical Suppress Indicator
Number of HCPCS Associated With Medical Services 17
Number of Medicare Beneficiaries With Medical 816
Number of Medical Services 34617
Total Medical Submitted Charge Amount 957739.16
Total Medical Medicare Allowed Amount 450091.05
Total Medical Medicare Payment Amount 344853.7
Total Medical Medicare Standardized Payment Amount 265485.49
Average Age of Beneficiaries 69
Number of Beneficiaries Age Less 65 136
Number of Beneficiaries Age 65 to 74 478
Number of Beneficiaries Age 75 to 84 182
Number of Beneficiaries Age Greater 84 20
Number of Female Beneficiaries 500
Number of Male Beneficiaries 316
Number of Non-Hispanic White Beneficiaries 617
Number of Black or African American Beneficiaries 59
Number of Asian Pacific Islander Beneficiaries
Number of Hispanic Beneficiaries 67
Number of American Indian/Alaska Native Beneficiaries
Number of Beneficiaries With Race Not Elsewhere Classified 43
Number of Beneficiaries With Medicare & Medicaid Entitlement 100
Number of Beneficiaries With Medicare Only Entitlement 716
Percent (%) of Beneficiaries Identified With Atrial Fibrillation 0.06
Percent (%) of Beneficiaries Identified With Alzheimer's Disease or Dementia 0.04
Percent (%) of Beneficiaries Identified With Asthma 0.22
Percent (%) of Beneficiaries Identified With Cancer 0.1
Percent (%) of Beneficiaries Identified With Heart Failure 0.07
Percent (%) of Beneficiaries Identified With Chronic Kidney Disease 0.15
Percent (%) of Beneficiaries Identified With Chronic Obstructive Pulmonary Disease 0.08
Percent (%) of Beneficiaries Identified With Depression 0.2
Percent (%) of Beneficiaries Identified With Diabetes 0.26
Percent (%) of Beneficiaries Identified With Hyperlipidemia 0.61
Percent (%) of Beneficiaries Identified With Hypertension 0.55
Percent (%) of Beneficiaries Identified With Ischemic Heart Disease 0.24
Percent (%) of Beneficiaries Identified With Osteoporosis 0.14
Percent (%) of Beneficiaries Identified With Rheumatoid Arthritis / Osteoarthritis 0.42
Percent (%) of Beneficiaries Identified With Schizophrenia / Other Psychotic Disorders 0.01
Percent (%) of Beneficiaries Identified With Stroke 0.03
Average HCC Risk Score of Beneficiaries 0.7882

Medicare Part D Prescribers

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type Allergy/ Immunology
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills 627
Number of Standardized 30-Day Fills 920
Aggregate Cost Paid for All Claims 117203.04
Number of Day's Supply for All Claims 26508
Number of Medicare Beneficiaries 152
Number of Claims, Including Refills, for Beneficiaries Age 65+ 421
Including Refills, for Beneficiaries Age 65+ 685
Beneficiaries Age 65+ 107811.47
Number of Day's Supply for All Claims for Beneficaries Age 65+ 19566
Number of Medicare Beneficiaries Age 65+ 124
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst
Total Claims of Brand-Name Drugs 137
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills 490
Aggregate Cost Paid for Generic Drugs 12395.98
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst
Total Claims of Other Drugs, Including Refills 0
Aggregate Cost Paid for Other Drugs 0
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans 103
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans 6673.83
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans 524
Aggregate Cost Paid for Claims Filled by 110529.21
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst
Number of Claims for Beneficiaries Covered by Low-Income Subsidy 252
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy 15229.44
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy 375
by Low-Income Subsidy 101973.6
Total Claims of Opioid Drugs, Including 0
Aggregate Cost Paid for Opioid Drugs 0
Opioid Claims 0
Opioid_Tot_Clms divided by the Tot_Clms 0
Total Claims of Long-Acting Opioid Drugs 0
Aggregate Cost Paid for Long-Acting Opioid 0
Number of Day's Supply of All Long-Acting 0
Long-Acting Opioid Claims 0
Opioid_LA_Tot_Clms divided by the
Total Claims of Antibiotic Drugs, Including 12
Aggregate Cost Paid for Antibiotic Drugs 80.96
Antibiotic Claims 12
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst
Including Refills, for Beneficiaries Age 65+ 0
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+ 0
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims 0
Average Age of Beneficiaries 69.052631579
Number of Beneficiaries Age Less Than 65
Number of Beneficiaries Age 65 to 74 77
Number of Beneficiaries Age 75 to 84 39
Number of Female Beneficiaries 91
Number of Male Beneficiaries 61
Number of Non-Hispanic White 102
Number of Black or African American 23
Number of Asian Pacific Islander
Number of Hispanic Beneficiaries 14
Number of American Indian/Alaskan NativeBeneficiaries
Number of Beneficiaries with Race Not
Only Entitlement 118
Average Hierarchical Condition Category 0.99524212

More Providers in west-nyack , ny

Dr. peter logalbo in Other Directories

Provider don't have other directory link yet.